As the four Artemis II astronauts looped around the moon this week before their return trip to Earth, so did four transparent chips, each about the size of a USB thumb drive and seeded with their bone ...

A New York City father is desperately seeking a donor to save his teenage son’s life. Max Uribe, now 15 and a high-school freshman, has just weeks until he will need to be hospitalized with a rare ...

For years, one of the most powerful weapons against certain blood cancers, called CAR-T therapy, has required an elaborate process: Doctors extract a patient’s immune cells, ship them to a specialized ...

When Marrow opened its West Village location in 2018, the concept of a butcher shop and restaurant was novel. You’d wind your way through a tidy butcher shop into an industrial dining room, large ...

On her best days, Tatyana Thompson’s pain was at a level five. Some days, it would stay that way, a persistent throb in her joints, her hands, her back. On other days, if she was dehydrated or was hit ...

BMT has poened its Digital Innovation & Simulation Centre (DISC) at the organisation’s Fareham site in the UK - a facility designed to provide a premium environment for high‑value simulation, ...

Simulator-style video games are designed to scale in complexity, allowing players to engage at anything from a casual level to highly detailed, realistic simulation. Microsoft Flight Simulator, for ...

Last March, it quickly became clear something was wrong with 3-year-old Avry Jo Schapansky. After a week-long cruise with her family, she had trouble walking once she was back on land in her Bastrop ...

Bone health relies on a balance between osteoblasts (builders) and osteoclasts (recyclers). Peak bone mass occurs in early adulthood; deficiencies during this window amplify fracture risks later in ...

A map of the immune cell landscape found in the bone marrow of patients with multiple myeloma could shed light on how the immune system interacts with cancerous plasma cells. It could also help ...

CD7 is an attractive target for chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory T-cell acute lymphoblastic leukemia (ALL). Supportive results of first-in-human studies of base ...